GP
AVNR

GLG Partners’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

GLG Partners’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-122,000
Closed -$2.07M – 508
2014
Q4 		$2.07M Buy
+122,000
New +$1.72M 0.06% 237

GLG Partners's AVNR Position: Q1 2015 in Review

GLG Partners sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 122,000 shares — an estimated $2.07M sold.

GLG Partners first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $2.07M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • GLG Partners reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • GLG Partners sold 122,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.07M.
  • GLG Partners first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • GLG Partners's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.07M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on GLG Partners's 13F filing for Q1 2015, filed 15 May 2015.